Jonathon B. Cohen, MD, discusses the biggest challenge in treating mantle cell lymphoma and how these challenges can be overcome.
Jonathon B. Cohen, MD, assistant professor, department of hematology and medical oncology, Winship Cancer Institute, Emory University School of Medicine, discusses the biggest challenge in treating mantle cell lymphoma (MCL) and how these challenges can be overcome.
The real challenge with MCL is that it is a rare disease that can present with very different types of behaviors, Cohen says. A physician may only see 1 of these patients once or twice a year, and all of these patients will present different clinical behavior.
This has made treating patients with MCL a challenge. In the past, Cohen says if a patient could receive intensive therapy, they were given that treatment. If they were not able to receive it, they didn’t. In some cases it worked while in others it didn’t.